0
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
ARTICLE |

Necrosis Following Administration of Levarterenol During Shock

C. ALLEN WALL, M.D.; C. ROLLINS HANLON, M.D.
AMA Arch Surg. 1956;72(2):332-335. doi:10.1001/archsurg.1956.01270200148026.
Text Size: A A A
Published online

We have recently seen seven instances of tissue necrosis when levarterenol (Levophed) was used to raise the blood pressure during a period of acute hypotension. Similar cases have been previously reported, and we are aware of many unreported instances. In view of the widespread use of vasopressor agents to combat shock, one may expect an increased number of such complications in the future, unless more caution is observed.

The mechanism by which levarterenol raises blood pressure is probably that of generalized vasoconstriction producing increased peripheral resistance. One might possibly explain the occurrence of local tissue necrosis following the intravenous administration of levarterenol on the basis of intense vasospasm. This spasm is manifested not only in the smaller arteries and veins but also in the vasa vasorum. It is possible that local tissue irritation in association with extravenous placement of the solution may be a factor. These two mechanisms might act

Topics

Sign in

Create a free personal account to sign up for alerts, share articles, and more.

Purchase Options

• Buy this article
• Subscribe to the journal

First Page Preview

View Large
First page PDF preview

Figures

Tables

References

Correspondence

CME
Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.
Submit a Comment

Multimedia

Some tools below are only available to our subscribers or users with an online account.

Sign in

Create a free personal account to sign up for alerts, share articles, and more.

Purchase Options

• Buy this article
• Subscribe to the journal

Related Content

Customize your page view by dragging & repositioning the boxes below.

Jobs
brightcove.createExperiences();